Key Insights into the Veterinary Intravenous (IV) Solutions Market: Trends, Growth Rate, and Opportunities Through 2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Veterinary Intravenous (IV) Solutions Market?
The veterinary intravenous (IV) solutions market is projected to expand due to an uptick in the occurrence of several animal diseases. Animal diseases, which can impact an animal’s health and functionality, include conditions like anthrax, leptospirosis, rabies, and canine distemper, among others. The increased frequency of such diseases can be attributed to factors like intensive farming habits, wildlife overrun, and resistance to antibiotics. These IV solutions are crucial for animals suffering from diseases that cause dehydration, like severe infections or gastroenteritis, as they help maintain hydration levels and support overall health. For example, AVMA Publications, the publishing division of the American Veterinary Medical Association, reported in July 2024 that approximately 345 domestic animals were confirmed to have rabies in 2022, reflecting a 10.9% hike from the 311 cases in 2021. Hence, the rise in animal disease prevalence is propelling the veterinary IV solutions market.
Veterinary Intravenous (IV) Solutions Driver: Growing Spending on Animal Health Products Fuels Veterinary IV Solutions Market
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20686&type=smp
How Will the Growth Rate of theVeterinary Intravenous (IV) Solutions Market Impact Industry Trends by 2034?
The market size of veterinary intravenous (IV) solutions has witnessed significant growth recently. It is predicted to increase from $1.5 billion in 2024 to $1.62 billion in 2025 with a compound annual growth rate (CAGR) of 8.1%. Factors responsible for this expansion in the historical phase include the growth in the count of veterinary clinics, an increase in dehydration cases, a surge in livestock farming, a boost in the numbers of pets, and advances in veterinary diagnostics.
It is projected that the veterinary intravenous (IV) solutions market will experience significant growth in the coming years. The value of the market is expected to reach $2.19 billion by 2029, with a compound annual growth rate (CAGR) of 7.8%. The predicted growth during the forecast period can be linked to factors such as the growing acceptance of pet insurance, an increase in animal healthcare expenses, heightened awareness of animal health care, a rise in the prevalence of animal diseases, and an expansion in pet insurance coverage. Key trends forecasted for this period involve technological advancements, variation in product formulations, the inclusion of telemedicine, the development of superior veterinary intravenous (IV) delivery systems, and the emergence of intelligent veterinary intravenous (IV) systems.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20686
What Are the Key Market Innovations in theVeterinary Intravenous (IV) Solutions Market Over the Coming Years?
Prominent companies in the veterinary intravenous (IV) solutions market are now prioritizing the development of advanced products like fluoroquinolone to enhance their effectiveness and safety metrics. Fluoroquinolones represent a potent category of antibiotics deployed in both human and veterinary healthcare to combat various bacterial infections, with the option for careful management to reduce the likelihood of resistance and adverse effects. For example, Elanco, a pharmaceutical company out of the United States, unveiled Pradalex, a pradofloxacin injection solution in April 2024 that received approval from the U.S. Food and Drug Administration (FDA). The U.S health organization gave clearance for its use in swine, aimed at tackling swine respiratory disease (SRD) linked to bordetella bronchiseptica, Glaesserella (Haemophilus) parasuis, Pasteurella multocida, streptococcus suis, and mycoplasma hyopneumoniae. Pradalex, as a 3rd generation fluoroquinolone, is rated as a critically important antimicrobial. The labeling on the drug emphasizes that it should only be employed after other non-fluoroquinolone therapeutic solutions have been considered.
Who Are the Top Companies Driving Innovation and Growth in theVeterinary Intravenous (IV) Solutions Market?
Major companies operating in the veterinary intravenous (IV) solutions market are Merck & Co. Inc., Baxter International Inc., Zoetis Inc., Fresenius Kabi AG, Elanco Animal Health Incorporated, B. Braun Melsungen AG, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol SA, Norbrook Laboratories Limited, Ceva Santé Animale, Revival Animal Health Inc., Aromor Animal Health, Jorgensen Laboratories LLC, Pharmacosmos AS, Sykes Veterinary International Pty Ltd., Rusoma Laboratories Private Limited, Patterson Companies Inc., NexGen Veterinary, Soxa Formulations & Research Pvt. Ltd
Order Your Report Now For A Swift Delivery:
Which Key Market Segments Comprise the Veterinary Intravenous (IV) Solutions Market and Drive Its Revenue Growth?
The veterinary intravenous (IV) solutions market covered in this report is segmented –
1) By Product: Isotonic Crystalloids, Dextrose Solutions, Synthetic Colloids, Natural Colloids, Parenteral Nutrition
2) By Animal Type: Companion Animals, Production Animals
3) By End-User: Veterinary Hospitals And Clinics, Research Institutes, Other End-Users
Subsegments:
1) Isotonic Crystalloids: Normal Saline (0.9% NaCl), Lactated Ringer’s Solution, Dextrose in Water (D5W), Ringer’s Solution, Balanced Electrolyte Solutions
2) Dextrose Solutions: Dextrose 5% in Water (D5W), Dextrose 10% in Water (D10W), Dextrose 20% in Water (D20W), Dextrose 50% in Water (D50W)
3) Synthetic Colloids: Hydroxyethyl Starch (HES), Dextran, Gelatins
4) Natural Colloids: Albumin, Fresh Frozen Plasma (FFP), Blood Products
5) Parenteral Nutrition: Total Parenteral Nutrition (TPN) Solutions, Partial Parenteral Nutrition Solutions, Lipid Emulsions, Amino Acid Solutions
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=20686&type=smp
Which Regions Are Emerging as Leaders in the Veterinary Intravenous (IV) Solutions Market?
North America was the largest region in the veterinary intravenous (IV) solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary intravenous (IV) solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Veterinary Intravenous (IV) Solutions Market 2025, By The Business Research Company:
Veterinary Biologics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report
Veterinary Hematology Analyzers Global Market Report 2025
Veterinary Telehealth Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-telehealth-market
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
